FDA requires additional labeling for OTC analgesics and antipyretics - MPR
Links shared publicly online about this topic.
- 2,078total visits
FDA requires additional labeling for OTC analgesics and antipyretics - MPR
empr.com —
The FDA has issued a final rule that requires manufacturers of over-the-counter (OTC) pain relievers and fever reducers to revise their labeling to include warnings about potential safety risks (eg, internal bleeding, liver damage, concomitant warfarin therapy) associated with the use of these drugs and to prominently display the active ingredients on the drug labels of both the packages and bottles.
View full resource at empr.com
Tags: Fever, Pain, Drug, FDA, Anti-Clotting Medication, Anticoagulant, Analgesic Medication, Coumadin
Most Recently Shared on April 30, 2009 at 3:26 pm By:
MPR News: FDA requires additional labeling for OTC analgesics and antipyretics: The FDA has issued a fi.. http://tinyurl.com/cptek3
Advertisement
